fashion -WSS

fashion

author：knowledge 2025-09-06 03:53:53 - browse：5194

Silhouetted hands passing money. -- health business coverage from STAT — Adobe

The federal government has started penalizing Medicare Advantage insurers that have one common, glaring problem: Faulty technology systems are leading to people paying more for care and coverage than they should be.

The Centers for Medicare and Medicaid Services fined three different Medicare Advantage plans this month, each one getting dinged differently for the way they overcharged their members. The fines are minuscule for the insurance companies — roughly equivalent to some pennies under a couch cushion — but they could serve as warnings for companies to clean up their compliance and IT infrastructure before regulators knock on their doors again.

“Just the knowledge that CMS will be back one day and that you better have this fixed, I think, does have a sentinel effect,” said Philip Legendy, an attorney at Ballard Spahr who represents Medicare Advantage plans. “And if you’re doing it over and over, it could be viewed as intentional.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Novo Nordisk to buy Cardior, building up pipeline of heart drugs

hotspot

WSS

Erich Jarvis studies song birds to learn about human stuttering

Infant mortality in U.S. rose last year for first time in decades: CDC

Surgeons perform first xenotransplant using CRISPR'd pig kidney

Key Senate panel to consider PBM, drug pricing reform package

With Wegovy coverage, Medicare patients may face high costs

Bring on the sabbaticals for nurses

hotspot

fashion

focus

The cancer drug shortage isn’t new — and neither are the solutions

Medical devices makers are asking for forgiveness, not permission

New air purifier tech could be key to improving indoor air quality

After Sarepta trial failure, Duchenne families brace for more debate

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Pfizer, Moderna say biotech, pharma drug development is a sprint

Psychedelics group wrestles with new pharma identity

Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

How to save PrEP access — and even expand it

U.K. officials, researchers try to ease path for bespoke genetic treatments

focus

Lung cancer screening guidelines updated for cigarette smokers

Readout LOUD podcast, live from the STAT Breakthrough Summit East

Texas board proposes rules on abortion law emergency exemption

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

'Patient friction coefficient' can gauge a clinical trial's patient burden

hotspot

hotspot

Wikipedia

leisure time